Authors
Judd L Walson, Phelgona A Otieno, Margaret Mbuchi, Barbra A Richardson, Barbara Lohman-Payne, Steve Wanyee Macharia, Julie Overbaugh, James Berkley, Eduard J Sanders, Michael H Chung, Grace C John-Stewart
Publication date
2008/8/20
Journal
Aids
Volume
22
Issue
13
Pages
1601-1609
Publisher
LWW
Description
Objective:
Several co-infections have been shown to impact the progression of HIV-1 infection. We sought to determine if treatment of helminth co-infection in HIV-1-infected adults impacted markers of HIV-1 disease progression.
Design:
To date, there have been no randomized trials to examine the effects of soil-transmitted helminth eradication on markers of HIV-1 progression.
Methods:
A randomized, double-blind, placebo-controlled trial of albendazole (400 mg daily for 3 days) in antiretroviral-naive HIV-1-infected adults (CD4 cell count> 200 cells/μl) with soil-transmitted helminth infection was conducted at 10 sites in Kenya (Clinical Trials. gov NCT00130910). CD4 and plasma HIV-1 RNA levels at 12 weeks following randomization were compared in the trial arms using linear regression, adjusting for baseline values.
Results:
Of 1551 HIV-1-infected individuals screened for helminth infection, 299 were helminth …
Total citations
200820092010201120122013201420152016201720182019202020212022202320244151710132485794565121